Daily Judi: Friday, October 21, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
Ian Sherr, at CNET, reports that tech giant Apple has sued medical device maker, Masimo, over its disputed blood oxygen censor. In 2020, Masimo sued Apple for patent infringement.
As the COVID-19 vaccine shifts from government contracts to the private sector, Pfizer will raise its price to around $120 per dose. (BioPharma Dive)
Eliza Strickland details the development of a neuroprosthetic nose by scientists at Virginia Commonwealth University (VCU), in Richmond, Virginia. The device is intended for those who lost their sense of smell to brain injury, COVID-19, or other illnesses. (IEEE Spectrum)
Meanwhile, Singapore will extend its cybersecurity legislation to hospital medical devices. (Computer Weekly)
The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team AG Mednet will be there!
Our Culture
"The Judi platform is purpose-built to drive clinical trial success—cloud-based, secure, collaborative. Our greatest strength, above all else, is our people."
–Abraham Gutman, President & CEO
About Judi
Judi empowers and enhances the world's clinical trial ecosystems. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.
